Log in Free sign up

Evolent Health (EVH) News and press releases

News

From Benzinga Pro

What 6 Analyst Ratings Have To Say About Evolent Health

Analyst Ratings

Within the last quarter, Evolent Health (NYSE:EVH) has observed the following analyst ratings:

RBC Capital Maintains Outperform on Evolent Health, Raises Price Target to $44

News, Price Target, Analyst Ratings

RBC Capital analyst Sean Dodge maintains Evolent Health (NYSE:EVH) with a Outperform and raises the price target from $40 to $44.

BTIG Maintains Buy on Evolent Health, Raises Price Target to $50

News, Price Target, Analyst Ratings

BTIG analyst David Larsen maintains Evolent Health (NYSE:EVH) with a Buy and raises the price target from $45 to $50.

Piper Sandler Maintains Overweight on Evolent Health, Raises Price Target to $40

News, Price Target, Analyst Ratings

Piper Sandler analyst Jessica Tassan maintains Evolent Health (NYSE:EVH) with a Overweight and raises the price target from $35 to $40.

12 Health Care Stocks Moving In Tuesday's After-Market Session

Gainers Applied DNA Sciences (NASDAQ:APDN) stock rose 90.0% to $5.32 during Tuesday's after-market session. At the close, Applied DNA Sciences's trading volume reached 28.8 million shares. This is 19228.0% of its average volume over the last 100 days.

Evolent Health Q2 EPS $0.10 Beats $0.04 Estimate, Sales $319.90M Beat $297.77M Estimate

Evolent Health (NYSE:EVH) reported quarterly earnings of $0.10 per share which beat the analyst consensus estimate of $0.04 by 150 percent. This is a 600 percent increase over losses of $(0.02) per share from the same

Earnings Scheduled For August 2, 2022

Earnings, News, Pre-Market Outlook, Markets

Companies Reporting Before The Bell • Ferrari (NYSE:RACE) is expected to report quarterly earnings at $1.27 per share on revenue of $1.22 billion.

Evolent Health's Earnings: A Preview

Evolent Health (NYSE:EVH) is set to give its latest quarterly earnings report on Tuesday, 2022-08-02. Here's what investors need to know before the announcement. Analysts estimate that Evolent Health will report an earnings per share (EPS) of $0.04.

Benzinga's Top Ratings Upgrades, Downgrades For July 29, 2022

Upgrades, Downgrades, Initiation, Intraday Update, Analyst Ratings

RBC Capital Initiates Coverage On Evolent Health with Outperform Rating, Announces Price Target of $40

News, Price Target, Initiation, Analyst Ratings

RBC Capital analyst Sean Dodge initiates coverage on Evolent Health (NYSE:EVH) with a Outperform rating and announces Price Target of $40.

Evolent Expands Its Portfolio For Musculoskeletal Conditions With This Deal

Biotech, Earnings, M&A, News, Health Care, General

Evolent Health to Acquire IPG from TPG Growth for $375M Plus Additional Contingent Consideration of up to $87M

Evolent Health, Inc.

4 Analysts Have This to Say About Evolent Health

Analyst Ratings

Evolent Health (NYSE:EVH) has observed the following analyst ratings within the last quarter:

Cowen & Co. Maintains Outperform on Evolent Health, Raises Price Target to $50

News, Price Target, Analyst Ratings

Cowen & Co. analyst Charles Rhyee maintains Evolent Health (NYSE:EVH) with a Outperform and raises the price target from $48 to $50.

Press releases

From Benzinga Pro

Evolent Health to Participate in the CG Growth Conference

WASHINGTON, Aug. 10, 2022 /PRNewswire/ -- Evolent Health, Inc. (NYSE:EVH) ("Evolent"), a health care company that delivers proven clinical solutions to payers and providers, today announced that Chief Executive

Evolent Health Announces Second Quarter 2022 Results

Earnings, Press Releases

Announces Four Operating Partner Additions WASHINGTON, Aug. 2, 2022 /PRNewswire/ -- Evolent Health, Inc. (NYSE:EVH), a health care company that delivers proven clinical and administrative solutions to payers and

Evolent Health Named to Parity.org's Best Companies for Women to Advance List 2022

Company makes the ParityLIST for the third straight year. WASHINGTON, Aug. 1, 2022 /PRNewswire/ -- Evolent Health, Inc. (NYSE:EVH), a health care company that delivers proven clinical and administrative solutions to

Evolent Health, Inc. to Release Second Quarter Operating Results and Host Conference Call on Tuesday, August 2, 2022

WASHINGTON, July 15, 2022 /PRNewswire/ -- Evolent Health, Inc. (NYSE:EVH), a health care company that delivers proven clinical and administrative solutions to payers and providers, today announced it will release its

Shareholder Alert - The M&A Class Action Firm Announces an Investigation of Evolent Health, Inc. - EVH

NEW YORK, June 30, 2022 /PRNewswire/ -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the "M&A Class Action Firm"), a national securities firm

EVOLENT HEALTH TO ACQUIRE IPG

Earnings, Press Releases

- Expected to Accelerate Evolent Health's Position as a Leading Provider of Value-Based Specialty Care Solutions - Expands Evolent's Value-Based Specialty Care Solutions Portfolio to Musculoskeletal Conditions-

SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Evolent Health, Inc.

Wilmington, Delaware--(Newsfile Corp. - May 27, 2022) - Rigrodsky Law, P.A. is investigating potential claims against the officers and directors of Evolent Health, Inc. (NYSE:EVH) on behalf of stockholders.To learn more